GlassScriptPrepare for your visit
Tena Rallis
Dermatology · New York, NY · NPI 1194194951
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$944.86
in general payments reported to CMS, 2019-2025 · $43.67 in 2025
The $43.67 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Who reported paying
General payments only, top 6 by amount.
- Dermavant Sciences, INC. $322.48
- Ucb, INC. $154.12
- Arcutis Biotherapeutics, INC. $128.87
- Abbvie INC. $125.25
- Incyte Corporation $49.20
- Pfizer INC. $39.50
Drugs and devices associated with these payments
Vtama Bimzelx Zoryve Skyrizi Opzelura Cibinqo Litfulo Adbry Winlevi Rinvoq Seysara Sotyktu
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Tena Rallis listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1360527/tena-rallis